Rybelsus is a glucagon-like peptide-1 (GLP-1) agonist available as a tablet. It is used to treat type 2 diabetes. Metformin ...

Rybelsus is an oral tablet prescribed for type 2 diabetes. It’s a brand-name drug, and it’s not available as a generic medication. The cost of Rybelsus can vary, but savings are available. In ...

Medically reviewed by Lindsay Cook, PharmDMedically reviewed by Lindsay Cook, PharmD When comparing Rybelsus vs. Ozempic, you ...

The FDA approval last Friday of Novo Nordisk’s Rybelsus as the first orally-active GLP-1 agonist is only the first challenge facing the company as it pursues its blockbuster sales targets for ...

Weight loss drug Rybelsus ® may cause serious health complications like gastroparesis (stomach paralysis) or bowel obstructions. Filing a Rybelsus lawsuit may allow you to seek compensation for the ...

The EMA's main advisory committee has backed approval of Novo Nordisk's oral GLP-1 agonist Rybelsus, a key pipeline drug in its type 2 diabetes franchise. Rybelsus (semaglutide) is the first GLP-1 ...

GLP-1 agonists have taken the pharma world by storm, and Novo Nordisk has been at the forefront of it all thanks to blockbuster drug semaglutide, which it sells as Ozempic, Wegovy and Rybelsus.